Photo credit: commons.wikimedia.org

— Warren Buffett

A five-year holding period is a useful test of whether a stock has rewarded patient capital through both price performance and dividend income. For UnitedHealth Group Inc (NYSE: UNH), that test produced a modest result: a $10,000 investment made on 10/21/2021 grew to $10,375.52 by 10/20/2026, assuming dividends were reinvested. That equates to a total return of 3.78% and an annualized return of 0.74%.

The key point is that UnitedHealth’s five-year total return was meaningfully better than its share-price change alone, but still subdued in absolute terms. The stock declined over the period on a price basis, and dividends helped offset part of that weakness through reinvestment.

UNH 5-Year Return Details

UNH 5-Year Return Details
Start date:	10/21/2021	$10,000 10/21/2021   $10,375 10/20/2026
End date:	10/20/2026
Start price/share:	$442.28
End price/share:	$419.26
Starting shares:	22.61
Ending shares:	24.75
Dividends reinvested/share:	$38.90
Total return:	3.78%
Average annual return:	0.74%
Starting investment:	$10,000.00
Ending investment:	$10,375.52

In practical terms, the position generated only a small cumulative gain over five years. The stock price fell from $442.28 to $419.26, so nearly all of the positive result came from cash distributions that were reinvested into additional shares. Starting with 22.61 shares, dividend reinvestment increased the holding to 24.75 shares by the end of the period.

What Drove the Result

There are two moving parts in any long-term total return calculation:

• Share-price performance: UNH declined by roughly 5.2% over the period based on the starting and ending prices shown above.
• Dividend income and reinvestment: $38.90 per share in dividends, reinvested over time, helped turn a negative price return into a modest positive total return.

This distinction matters. Looking only at the share chart would understate what a buy-and-hold investor actually earned, while looking only at the ending account value would obscure how dependent the outcome was on dividends rather than capital appreciation.

[These numbers were computed with the Dividend Channel DRIP Returns Calculator.]

Dividend Yield and Yield on Cost

Based on the most recent annualized dividend rate of $9.28 per share, UNH has a current dividend yield of approximately 2.21% using the ending share price of $419.26.

Another way to frame the dividend is through yield on cost, which compares the current annualized dividend to the original purchase price. Using the starting price of $442.28, the yield on cost is about 2.10%.

That figure is useful because it shows how the income stream has evolved relative to the original capital committed. It is not a measure of current opportunity cost, but it does help illustrate the income characteristics of a long-held position.

A Concise Takeaway

For this five-year period, UnitedHealth Group delivered a low single-digit total return, with dividends doing most of the work. The investment preserved capital in nominal terms and produced a slightly positive compounded result, but it did not generate strong overall appreciation. For long-term investors evaluating UNH, the period underscores a basic point: total return depends not just on business quality or dividend growth, but also on the entry valuation and the market’s willingness to continue assigning a premium multiple.